AltraTech

Pre-clinical

Cork, IrelandFounded 2016altratech.com

AltraTech is pioneering a next-generation diagnostic platform designed to integrate serological and molecular testing into a single, rapid point-of-care device. The company's mission is to transform diagnostic workflows by providing comprehensive, multi-parameter results from a single sample, addressing needs in clinical triage, drug development, and personal health monitoring. Based in Cork, Ireland, AltraTech is developing a versatile technology with applications across infectious disease, chronic condition management, and pharmaceutical R&D.

Founded

2016

Focus

Diagnostics

AI Company Overview

Technology Platform

A multianalyte point-of-care diagnostic platform that uniquely integrates serology (antibody/antigen) and viral nucleic acid testing in a single device from one patient sample.

Funding History

Total raised: $3.8M

Seed$3.8MUndisclosedNov 15, 2020

Opportunities

The primary growth opportunity lies in capturing share in the large and growing point-of-care diagnostics market by offering a uniquely integrated solution.

Additional opportunities include creating a new tool category for pharmaceutical biomarker discovery and expanding into the burgeoning consumer home testing market with a more sophisticated product.

Risk Factors

Key risks include the high technical difficulty of integrating two distinct testing modalities, significant regulatory hurdles for a novel device, challenges in securing adequate funding as a private startup, and intense competition from large, established diagnostics companies.

Competitive Landscape

AltraTech faces competition from leaders in molecular POC testing (e.g., Cepheid, BioFire) and rapid serology (e.g., Abbott, QuidelOrtho). Its main differentiation is the proposed native integration of both test types in a single device, aiming to provide a more comprehensive diagnostic result than current standalone solutions.